eflornithine has been researched along with Bright Disease in 1 studies
Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ketteler, M | 1 |
| Westenfeld, R | 1 |
| Gawlik, A | 1 |
| de Heer, E | 1 |
| Distler, A | 1 |
1 other study available for eflornithine and Bright Disease
| Article | Year |
|---|---|
Acute glomerular upregulation of ornithine decarboxylase is not essential for mesangial cell proliferation and matrix expansion in anti-Thy-1-nephritis.
Topics: Animals; Antibodies, Monoclonal; Biglycan; Cell Division; Eflornithine; Enzyme Inhibitors; Extracell | 2000 |